Related Experiment Video
Updated: May 5, 2026

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
Published on: August 11, 2008
Adverse Drug Reaction to First-Line Oral Antitubercular Drugs: An 8-Year Analysis from a Tertiary Centre in Eastern
Ratikanta Tripathy1, Pratima Singh2, Debasis Behera2
1Deparment of Pharmacology, KIMS, KIIT, Bhubaneswar, Odisha, India.
Background:
Tuberculosis (TB) is caused by Mycobacterium tuberculosis. Treatment regimen with the first-line anti-tubercular drug remains the foundation of treatment for drug-sensitive TB. The fixed-dose combination of drugs regime is associated with adverse drug reactions (ADRs) such as drug-induced liver injury (DILI), myalgia, arthralgia, hearing loss, gastrointestinal disturbances, visual disturbances, central nervous disorders and hypersensitivity reactions.
Aims:
This study aimed to analyse the spectrum and severity of ADRs with emphasis on DILI.
Methods:
This retrospective study was conducted from 2015 to 2023 at a tertiary care teaching hospital. A total of 108 patients were included in the study. The spectrum of ADRs was classified as per the World Health Organization systems organ classes. The seriousness of the reaction was classified as serious and non-serious. The severity of DILI was categorized into five grades.
Results:
A total of 126 ADRs were reported. DILI was the most reported ADR followed by vomiting and itching.
Conclusion:
This study seeks to enhance the clinicians' understanding of the diverse ADRs linked to anti-TB treatment, encouraging them to provide better patient counselling, prioritise safety and actively report even mild ADRs.
Insights
Adverse drug reactions (ADRs) are common with anti-tuberculosis (TB) treatment. Drug-induced liver injury (DILI) was the most frequent ADR reported, highlighting the need for vigilant monitoring and reporting.
Area of Science:
- Pharmacovigilance
- Infectious Diseases
- Clinical Pharmacology
Background:
- Tuberculosis (TB) treatment relies on first-line anti-tubercular drugs.
- Fixed-dose combinations are associated with various adverse drug reactions (ADRs).
- Common ADRs include drug-induced liver injury (DILI), myalgia, arthralgia, hearing loss, and gastrointestinal issues.
Purpose of the Study:
- To analyze the spectrum and severity of ADRs in TB patients.
- To specifically focus on drug-induced liver injury (DILI) as a significant ADR.
Main Methods:
- Retrospective study conducted between 2015 and 2023.
- Inclusion of 108 patients from a tertiary care teaching hospital.
- Classification of ADRs using WHO systems organ classes and seriousness criteria; DILI severity graded.
Main Results:
- A total of 126 ADRs were documented.
- Drug-induced liver injury (DILI) was the most frequently reported ADR.
- Vomiting and itching were also commonly reported ADRs.
Conclusions:
- Findings aim to improve clinicians' understanding of anti-TB treatment ADRs.
- Emphasizes the importance of patient counseling and safety prioritization.
- Encourages active reporting of all ADRs, including mild reactions.
More Related Videos
Related Concept Videos
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Therapeutic Drug Monitoring: Affecting Factors
Drug toxicity: Idiosyncratic Reactions

